Regulation of palmitoyl-CoA chain elongation by clofibric acid in the liver of Zucker fa/fa rats.
The regulation of palmitoyl-CoA chain elongation (PCE) by clofibric acid [2-(4-chlorophenoxy)-2-methylpropionic acid] was investigated in comparison with stearoyl-CoA desaturase (SCD) in the liver of obese Zucker fa/fa rats. The proportion of oleic acid in the hepatic lipids of Zucker obese rats is 2.7 times higher than that of lean littermates. The activities of PCE and SCD in the liver of Zucker obese rats were markedly higher than in lean rats, and the hepatic uptake of 2-deoxyglucose (2-DG) was also higher in Zucker obese rats compared with lean rats. The increased activities of SCD and PCE in Zucker obese rats were due to the enhanced expression of mRNA of both SCD1 and rat FA elongase 2 (rELO2), but not SCD2 or rELO1. The proportion of oleic acid in the liver was significantly increased by the administration of clofibric acid to Zucker obese rats, and the hepatic PCE activity and rELO2 mRNA expression, but not the SCD activity or SCD1 mRNA expression, were increased in response to clofibric acid treatment. By contrast, the activities of both PCE and SCD and the mRNA expression of SCD1 and rELO2 in the liver were increased by the treatment of Zucker lean rats with clofibric acid. Multiple regression analysis, which was performed to determine the relationships involving PCE activity, SCD activity, and the proportion of oleic acid, revealed that the three parameters were significantly correlated and that the standardized partial regression coefficient of PCE was higher than that of SCD. These results indicate that oleic acid is synthesized by the concerted action of PCE and SCD and that PCE plays a crucial role in the formation of oleic acid when Zucker fa/fa rats are given clofibric acid.
Toyama
Tomoaki
T
Faculty of Pharmaceutical Sciences, Josai University, Saitama 350-0295, Japan.
Kudo
Naomi
N
Mitsumoto
Atsushi
A
Kawashima
Yoichi
Y
D000123:Acetyltransferases / Q000378:metabolism*; D000818:Animals; D002995:Clofibric Acid / Q000494:pharmacology*; D000081031:Fatty Acid Elongases; D008099:Liver / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D009765:Obesity / Q000201:enzymology; D019301:Oleic Acid / Q000378:metabolism; D010171:Palmitoyl Coenzyme A / Q000378:metabolism*; D051381:Rats; D011924:Rats, Zucker; D013230:Stearoyl-CoA Desaturase / Q000378:metabolism
D010171:Palmitoyl Coenzyme A; D019301:Oleic Acid; D002995:Clofibric Acid; D013230:Stearoyl-CoA Desaturase; D000123:Acetyltransferases; D000081031:Fatty Acid Elongases